-
psnet.ahrq.gov/node/47356/psn-pdf
September 05, 2018 - A past WebM&M commentary discussed a task interruption due
to texting.
-
psnet.ahrq.gov/node/45967/psn-pdf
July 05, 2017 - A recent Annual Perspective discussed ongoing problems
with the root cause analysis process and described
-
psnet.ahrq.gov/node/39895/psn-pdf
September 21, 2011 - Mark Chassin, the
president of the Joint Commission, discussed the organization's approach to improving
-
psnet.ahrq.gov/node/38543/psn-pdf
April 27, 2010 - Two cases of preventable
readmissions are discussed in this AHRQ WebM&M commentary.
-
psnet.ahrq.gov/node/45900/psn-pdf
June 07, 2017 - An error associated with a mislabeled blood sample is discussed in a past WebM&M commentary.
-
psnet.ahrq.gov/node/41068/psn-pdf
September 29, 2017 - A case of a misunderstood verbal order that led to a serious error is discussed in this
AHRQ WebM&M
-
psnet.ahrq.gov/node/44818/psn-pdf
February 24, 2018 - A PSNet perspective on
the business case for patient safety discussed health care–associated infections
-
psnet.ahrq.gov/node/34013/psn-pdf
December 22, 2008 - While the intensive care unit represents the contextual
background for this review, a past study also discussed
-
psnet.ahrq.gov/node/38940/psn-pdf
November 25, 2009 - A case of an inadvertent medication overdose in an infant due to
inadequate parental education is discussed
-
psnet.ahrq.gov/node/44618/psn-pdf
February 10, 2016 - A prior WebM&M commentary
discussed tall man lettering as one strategy for improving the safety of look-alike
-
psnet.ahrq.gov/node/43856/psn-pdf
March 18, 2015 - As the studies identified focused primarily on environmental factors and few discussed
how behaviors
-
psnet.ahrq.gov/node/41958/psn-pdf
April 17, 2013 - An incident of wrong-site surgery is
discussed in an AHRQ WebM&M commentary.
-
psnet.ahrq.gov/node/37113/psn-pdf
March 24, 2011 - To date, published literature has not
documented the desired effect, as discussed in a recent commentary
-
psnet.ahrq.gov/node/43957/psn-pdf
June 21, 2015 - of preparation, facilitator responsibilities during the session, and
considerations for the content discussed
-
psnet.ahrq.gov/node/34774/psn-pdf
June 02, 2010 - and dangers inherent in medical progress,
from adverse drug reactions to unnecessary surgery, are discussed
-
psnet.ahrq.gov/node/37659/psn-pdf
March 02, 2011 - difficulty of interpreting and applying evidence from clinical trials to
patient safety efforts, as discussed
-
psnet.ahrq.gov/node/47204/psn-pdf
July 18, 2018 - A PSNet perspective discussed opioid overdose as a patient safety
problem.
-
digital.ahrq.gov/2018-year-review/research-dissemination/web-conferences
January 01, 2018 - The following presenters discussed their research on optimal design of EHRs to support clinical workflow … The following presenters discussed their research on strategies to improve medication management: Dr.
-
cds.ahrq.gov/sites/default/files/workgroups/221/feb-2017-cholesterol-wg-notes.docx
January 01, 2017 - Allergies are very rare and side effects can usually be discussed and worked through with the patient … and debilitating side effects, such as myalgia, may also be considered.
· Interventions:
· WG members discussed … Discuss Statin Therapy for the Prevention and Treatment of CVD eCQM/CDS Artifact
Not discussed.
-
digital.ahrq.gov/sites/default/files/docs/citation/r13hs024833-gill-final-report-2017.pdf
January 01, 2017 - In the evening, an invite-only talk for workgroup
participants offered over dinner discussed the relationship … Affordances and
deficiencies of various VR technologies were discussed for a variety of use cases. … An overview
of research findings were discussed from the Hank Virtual Environments Laboratory on how … In the afternoon, ideas that were discussed within each
breakout group of six were presented to the … This suggestion should be discussed prior to implementation; one of
the challenges we faced in structuring